Variability of ticagrelor antiplatelet responsiveness in Chinese ACS patients

被引：0
|
作者：
Yin, Tong [1 ]
Wang, Xuyun [1 ]
Liu, Jia [1 ]
Chen, Yundai [1 ]
机构：
[1] Chinese Peoples Liberat Army, Gen Hosp, Dept Cardiol, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2015.06.874
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW26-e0691
引用
收藏
页码：C227 / C227
页数：1
相关论文
共 50 条
  • [31] Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)
    Mangiacapra, Fabio
    Panaioli, Elena
    Colaiori, Iginio
    Ricottini, Elisabetta
    Pantano, Angelo Lauria
    Pozzilli, Paolo
    Barbato, Emanuele
    Di Sciascio, Germano
    CIRCULATION, 2016, 134 (11) : 835 - 837
  • [32] Modifiers of antiplatelet responsiveness
    Grdinic, A.
    Vojvodic, D.
    Djukanovic, N.
    Grdinic, A. G.
    Obradovic, S.
    Majstorovic, I.
    Rusovic, S.
    Vucinic, Z.
    Tavciovski, D.
    Ostojic, M.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S120 - S120
  • [33] Prasugrel and Ticagrelor Treatment Among Patients With ACS Is There a Need for a New Randomized Trial?
    Woehrle, Jochen
    Seeger, Julia
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (22) : 2281 - 2283
  • [34] Long vs. short dual antiplatelet therapy in ACS patients treated with prasugrel or ticagrelor and coronary revascularization: a propensity score analysis from the RENAMI registry
    Fioravanti, F.
    Bertaina, M.
    D'Ascenzo, F.
    Bongiovanni, F.
    Raposeiras-Roubin, S.
    Abu-Assi, E.
    Kinnaird, T.
    Ariza-Sole, A.
    Manzano-Fernandez, S.
    Templin, C.
    Velicki, L.
    Xanthopoulou, I.
    Cerrato, E.
    Rognoni, A.
    Luscher, T. F.
    EUROPEAN HEART JOURNAL, 2018, 39 : 652 - 652
  • [35] ONSET OF ANTIPLATELET EFFECT OF PRASUGREL AND TICAGRELOR IS DELAYED IN PATIENTS WITH ACUTE CORONARY SYNDROMES
    Nuehrenberg, Thomas G.
    Trenk, Dietmar
    Ferenc, Miroslaw
    Schmitz, Roland
    Leggewie, Stefan
    Stratz, Christian
    Valina, Christian
    Kienzle, Rolf-Peter
    Hochholzer, Willibald
    Neumann, Franz-Josef
    HEART, 2013, 99 : E160 - E160
  • [36] Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
    Khan, Hamzah
    Gallant, Reid
    Jain, Shubha
    Al-Omran, Mohammed
    De Mestral, Charles
    Greco, Elisa
    Wheatcroft, Mark
    Alazonni, Ashraf
    Abdin, Rawand
    Rand, Margaret L.
    Ni, Heyu
    Qadura, Mohammad
    MEDICINA-LITHUANIA, 2020, 56 (10): : 1 - 11
  • [37] Onset of antiplatelet effect of prasugrel and ticagrelor is delayed in patients with acute coronary syndromes
    Trenk, D.
    Ferenc, M.
    Schmitz, R.
    Nuehrenberg, T.
    Leggewie, S.
    Stratz, C.
    Valina, C.
    Kienzle, R-P
    Hochholzer, W.
    Neumann, F-J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 895 - 896
  • [38] Ticagrelor in ACS: redefining a new standard of care?
    Stone, Gregg W.
    LANCET, 2010, 375 (9711): : 263 - 265
  • [39] Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS
    Peng, Li
    Liu, Jun
    Qin, Liuan
    Liu, Jia
    Xi, Shaozhi
    Lu, Caiyi
    Yin, Tong
    THROMBOSIS RESEARCH, 2017, 157 : 97 - 102
  • [40] Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy?
    Vittoria Cammisotto
    Giuseppe Biondi-Zoccai
    Giacomo Frati
    Arturo Giordano
    American Journal of Cardiovascular Drugs, 2019, 19 : 377 - 379
12345